Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide.
Saved in:
| Title: | Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide. |
|---|---|
| Authors: | Wang Q; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Department of Dermatology, Changxing People's Hospital, Huzhou, China., Ren ZT; The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Wu HF; Department of Urology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Gu HC; The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Li XW; Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Tang ZL; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Feb 20; Vol. 16, pp. 1530919. Date of Electronic Publication: 2025 Feb 20 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
